#Positron Emission Tomography (PET) Systems market size | Explore Tumblr Posts and Blogs

organicbusinessconsulting · 2 months

Text

Global Imaging Workstations Market Size, Share and Demand Forecast 2031

The Global Imaging Workstations Market size was estimated at USD xx billion in 2021 and is expected to hit around USD xx billion by 2030, poised to grow at a compound annual growth rate (CAGR) of xx % from 2022 to 2030.

The term “Imaging Workstations” describes the secondary market for the market for computer-based systems that are used for the processing, analysis, and visualization of medical images. These workstations are used by healthcare professionals, including radiologists, to view and interpret various medical images, such as X-rays, CT scans, MRIs, and ultrasound images. Imaging workstations allow medical professionals to manipulate and enhance images to help diagnose and treat various medical conditions. The market for imaging workstations includes both hardware and software components and encompasses a variety of applications and use cases, including diagnostic imaging, clinical review, and research. The market is driven by technological advancements in medical imaging, an increasing prevalence of chronic diseases, and the growing demand for accurate and timely diagnosis.

The development of advanced imaging technologies and software solutions is one of the primary drivers of the imaging workstations market. Advancements in artificial intelligence (AI) and machine learning (ML) are allowing healthcare professionals to analyze and interpret medical images with greater accuracy and speed, thereby improving patient outcomes. The increasing prevalence of chronic diseases such as cancer, heart disease, and respiratory conditions is driving the demand for medical imaging services. As a result, healthcare providers are investing in imaging workstations to help diagnose and treat these conditions.

Download Free Sample Report

The growth of telemedicine is another key driver of the imaging workstations market. With telemedicine, medical professionals can remotely access and interpret medical images, allowing for faster diagnosis and treatment. Governments around the world are investing in healthcare infrastructure and technology to improve patient outcomes and reduce healthcare costs. This is driving the adoption of imaging workstations in both developed and developing countries. As healthcare spending continues to rise globally, healthcare providers are investing in advanced technologies, including imaging workstations, to improve patient care and outcomes.

The global imaging workstations market is highly competitive and fragmented, with the presence of several large and small players. The key players in the market are focusing on product innovation, strategic partnerships, mergers and acquisitions, and geographical expansion to maintain their market share and increase their customer base.

The competition in the market is primarily driven by technological advancements, product innovation, and pricing strategies. The players are constantly investing in research and development to improve their product offerings and stay ahead of the competition. They are also focused on providing customized solutions to meet the specific needs of their customers.

Market Segmentation:

Market Breakup: By Product Type

Standalone Workstations

Integrated Workstations

Market Breakup: By Modality

Magnetic Resonance Imaging (MRI)

Computed Tomography (CT)

Mammography

Positron Emission Tomography (PET)

Single-Photon Emission Computed Tomography (SPECT)

Market Breakup: By End-User

Hospitals

Diagnostic Imaging Centers

Research Institutes

Market Breakup: By Application

Cardiology

Oncology

Neurology

Orthopedics

Dental

Others

Click Here : https://organicmarketresearch.com/imaging-workstationsmarket

Regional Analysis

The size and scope of the global Imaging Workstations market vary by region and are important and expanding. Below is a quick summary of the industry’s regional analysis:

North America: The North American market is the largest market for imaging workstations and is driven by the presence of advanced healthcare infrastructure, high healthcare expenditure, and the adoption of new technologies. The United States is the major contributor to the market in this region.

Europe: The European market for imaging workstations is driven by the increasing prevalence of chronic diseases, the growing demand for early diagnosis, and the development of advanced imaging technologies. The major markets in this region include Germany, France, and the UK.

Asia-Pacific: The Asia-Pacific region is the fastest-growing market for imaging workstations, driven by the increasing healthcare expenditure, growing awareness about early diagnosis and treatment, and the presence of a large patient population. The major markets in this region include China, Japan, India, and South Korea.

South America: The South American market for imaging workstations is driven by the improving healthcare infrastructure and the growing demand for advanced medical technologies. Brazil is the major contributor to the market in this region.

Middle East & Africa: The Middle East & Africa market for imaging workstations is driven by the increasing healthcare expenditure, growing demand for advanced medical technologies, and the presence of a large patient population. The major markets in this region include Saudi Arabia, the UAE, and South Africa.

Overall, the imaging workstations market is growing in all regions due to the increasing prevalence of chronic diseases, the growing demand for advanced medical technologies, and the increasing healthcare expenditure. However, the rate of growth and market size vary across different regions.

Market Breakup By Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Competitive Landscape

The Imaging Workstations Industry competitive landscape provides details by competitor. Details included are company outline, company financials, revenue generated, market potential, investment in research and development, new market initiatives, worldwide occurrence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The overhead data points providing are only related to the businesses’ focus related to Imaging Workstations marketplace.

Major players operating in the Global Imaging Workstations Industry are:

General Electric Company

Siemens Healthineers AG

Koninklijke Philips N.V.

Canon Medical Systems Corporation

Fujifilm Holdings Corporation

Hologic, Inc.

Carestream Health, Inc.

Agfa-Gevaert N.V.

Accuray Incorporated

Capsa Healthcare

NDS Surgical Imaging LLC

Carl Zeiss Meditec AG

Esaote SpA

Pie Medical Imaging

Ziehm Imaging GmbH

Trending Reports:

https://organicmarketresearch.com/imaging-workstationsmarkethttps://organicmarketresearch.com/diy-pc-gaming-chassis-market

#Imaging Workstations Market #consulting firm #market research

0 notes

imarcmarketreport · 3 months

Text

Image-guided Therapy Systems Market Size, Trends and Opportunity 2024-2032

IMARC Group's report titled " Image-guided Therapy Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032", The global image-guided therapy systems market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/image-guided-therapy-systems-market/requestsample

Factors Affecting the Growth of the Image-guided Therapy Systems Industry:

Technological Advancements:

Innovations in medical imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and X-ray, are leading to the development of more advanced image-guided therapy systems. These advancements enable higher-resolution imaging, real-time monitoring, and improved accuracy in treatment delivery. Image-guided therapy systems are becoming more precise, efficient, and versatile, expanding their applications across various medical specialties. Clinicians benefit from enhanced visualization capabilities, allowing for more accurate diagnosis, treatment planning, and intervention. Patients also benefit from reduced procedure times and improved outcomes.

Increasing Prevalence of Chronic Diseases:

The growing demand for image-guided therapy systems on account of the rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, among the masses around the world is offering a positive market outlook. These conditions require complex and precise treatment interventions. In addition, image-guided procedures offer minimally invasive (MI) alternatives to traditional surgeries, providing patients with less discomfort, shorter recovery times, and improved quality of life. The increasing need for advanced technologies that can provide real-time imaging guidance during surgeries and other interventions is strengthening the market growth.

Rising Focus on MI Procedures:

The escalating demand for image-guided therapy systems due to increasing preferences for MI procedures over traditional surgeries is supporting the market growth. MI procedures offer various benefits, such as reduced postoperative pain and shorter hospital stays. Image-guided therapy systems play a crucial role in facilitating MI interventions by providing real-time imaging guidance to clinicians during procedures. These systems enable precise navigation and targeted delivery of therapies, enhancing treatment outcomes while minimizing risks to patients. Furthermore, healthcare providers and patients are becoming aware about the importance of advanced imaging technologies in modern healthcare delivery.

Leading Companies Operating in the Global Image-guided Therapy Systems Industry:

Analogic Corporation

Brainlab AG

FUJIFILM Holdings Corporation

General Electric Company

Karl Storz SE & Co. KG

Koninklijke Philips N.V.

Medtronic plc

Siemens Healthineers AG

Stryker Corporation

Varian Medical Systems Inc.

Image-guided Therapy Systems Market Report Segmentation:

By Product:

Ultrasound Systems

Computed Tomography (CT) Scanners

Positron Emission Tomography (PET)

Endoscopes

Magnetic Resonance Imaging (MRI)

X-ray Fluoroscopy

Others

Endoscopes represent the largest segment as they enable direct visualization of internal organs and structures without the need for open surgery.

By Application:

Cardiac Surgery

Neurosurgery

Orthopedic Surgery

Urology

Oncology Surgery

Gastroenterology

Others

Cardiac surgery holds the biggest market share on account of the increasing incidence of cardiovascular diseases among individuals.

By End Use:

Hospitals and Clinics

Ambulatory Surgical Centers

Research and Academic Institutions

Others

Hospitals and clinics account for the largest market share due to the rising focus on enhanced patient care.

Regional Insights:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

North America enjoys a leading position in the image-guided therapy systems market, which can be attributed to the presence of highly developed healthcare infrastructure with advanced medical facilities.

Global Image-guided Therapy Systems Market Trends:

The increasing employment of image-guided therapy systems among the geriatric population is impelling the market growth. Older adults are more susceptible to age-related health conditions that require advanced medical interventions. The growing prevalence of degenerative conditions and age-related injuries is offering a positive market outlook. These systems play a critical role in diagnosing age-related conditions, guiding treatment decisions, and monitoring disease progression in elderly patients. Additionally, older adults are preferring less invasive treatment options that offer quick recovery times and fewer complications.

The rising focus on personalized treatment approaches tailored as per individual patient characteristics is bolstering the market growth.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

#Image-guided Therapy Systems Market

0 notes

mrfr-blogs · 3 months

Text

Evaluating Market Size and Growth Potential in Diagnostic Imaging Market

Market Overview –

The diagnostic imaging market is anticipated to reach USD 49.66 billion by 2032, growing at a CAGR of 4.7% over the forecast period 2023-2032.

The Diagnostic Imaging Market encompasses a wide range of medical imaging technologies used to visualize internal body structures and diagnose various medical conditions. These imaging modalities include X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT).

The diagnostic imaging market is thriving, propelled by advancements in medical imaging technologies. Medical imaging plays a crucial role in disease detection, diagnosis, and treatment planning. With continuous innovation, such as AI integration and portable imaging devices, the market is witnessing sustained growth, meeting the increasing demand for accurate and efficient diagnostic solutions.

In recent years, the diagnostic imaging market has experienced significant growth globally due to several factors. Firstly, there has been increasing demand for diagnostic imaging procedures driven by factors such as aging populations, rising prevalence of chronic diseases, and advancements in imaging technology. Key players in this market include medical device manufacturers, imaging equipment suppliers, healthcare providers, and research institutions, collaborating to develop and commercialize innovative imaging solutions.

Moreover, advancements in imaging technology have led to the development of new imaging modalities with improved resolution, speed, and diagnostic accuracy. These advancements enable earlier detection of diseases, more precise treatment planning, and better monitoring of treatment response, ultimately leading to improved patient outcomes.

Additionally, there is growing interest in personalized imaging approaches tailored to individual patient characteristics, such as genetic profiles, disease stage, and treatment history. Personalized imaging techniques enable healthcare providers to optimize imaging protocols and treatment strategies based on each patient's unique needs, enhancing the efficacy and safety of medical imaging procedures.

Overall, the diagnostic imaging market presents opportunities for growth and innovation as it continues to evolve with advancements in technology and increasing demand for diagnostic imaging services worldwide. Efforts to develop new imaging modalities, improve imaging quality, and expand access to imaging services are essential for advancing healthcare practices and improving patient care.

Market Segmentation –

The global diagnostic imaging market has been segmented on the basis of product, source, and application.

Based on product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other products

The market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applications

The end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others.

Regional Analysis –

Regional analysis of the diagnostic imaging market is essential for understanding the adoption, trends, and dynamics of imaging modalities across different geographic regions. Diagnostic imaging plays a crucial role in healthcare by enabling the visualization of internal body structures for diagnosis, monitoring, and treatment planning. Factors such as healthcare infrastructure, reimbursement policies, and prevalence of diseases influence the demand for various imaging technologies in each region.

Developed regions like North America and Europe often lead in the adoption of advanced imaging modalities such as MRI, CT scans, and PET scans due to well-established healthcare systems, high healthcare spending, and early adoption of innovative medical technologies. In contrast, emerging economies in Asia-Pacific and Latin America are witnessing increasing demand for diagnostic imaging, driven by factors such as rising healthcare expenditure, improving access to healthcare services, and growing prevalence of chronic diseases. Additionally, variations in regulatory frameworks and cultural attitudes towards healthcare impact market dynamics and adoption rates across regions.

Conducting a comprehensive regional analysis enables stakeholders to identify market opportunities, tailor their marketing strategies, and address region-specific challenges such as regulatory compliance and market access. By understanding regional nuances, companies can optimize their market penetration efforts and better serve the diagnostic imaging needs of healthcare providers and patients worldwide.

Key Players –

The Diagnostic imaging company profiles include Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, Carestream Health, Esoate SpA, GE Healthcare, Toshiba Medical Systems Corporation, FUJIFILM Holdings Corporation, Siemens Healthcare Private Limited, Hitachi Medical Systems, Hologic Inc., and Shimadzu Corporation.

Related Reports –

Macrolide Antibiotics

Spinal Traction

Performance Enhancing Drugs

Vasectomy

For more information visit at MarketResearchFuture

#Diagnostic Imaging Market #Diagnostic Imaging Market Size #Diagnostic Imaging Market Share #Diagnostic Imaging Market Growth #Diagnostic Imaging Market Trends

0 notes

blog-site-for-market-research · 4 months

Text

Oral Cancer Diagnostics Market Size, By Region, And Segment Forecasts, 2023 - 2032

Market Overview

The Oral Cancer Diagnostics Market size is expected to reach USD 2.98 billion by 2032, growing at a 4.8% CAGR during the forecast period 2023-2032.

The oral cancer diagnostics market 2020 is anticipated to be majorly driven by on-going technological developments in endoscopy, biomarkers, and biopsy. The consumption of tobacco can increase cancer prevalence that is likely to surge the demand for advanced cancer screening tools, which can boost the market growth. Conventional diagnosis tests are time-consuming; therefore, the demand for advanced non-invasive cancer diagnostics is likely to rise, which is projected to augment the market in the assessment period. Furthermore, the surging investments by key players in the oral cancer diagnostic business are likely to strengthen the market in the forthcoming period.

On the other hand, lack of trained professionals is likely to hamper the market during the projection period. However, the availability of early diagnosis tools and the growing geriatric population are projected to counter the impeding factor that can aid in boosting the market.

Market Segmentation

The segmental analysis of the global oral cancer diagnostics market is done by indication, end-user, and diagnosis type.

The indication-based segments of the global oral cancer diagnostics market are oral cavity lymphomas, oral verrucous carcinoma, oral squamous cell carcinoma, mucoepidermoid carcinoma (salivary gland), and others.

The end-user-based segments of the global oral cancer diagnostics market are research and academic institutes, hospitals and clinics, and others.

The diagnosis type based segments of the global oral cancer diagnostics market are fluorescence imaging, biopsy, endoscopy, X-ray, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasonography, and others.

Regional Analysis

Based on the region, the global oral cancer diagnostics market trend is done by North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

As per the analysis by MRFR, the global market is anticipated to be dominated by the Americas. The region is predicted to procure the largest market share owing to the presence of prominent key players. The presence of advanced healthcare facilities is anticipated to strengthen the regional market in the coming period. Furthermore, the increasing incidence of oral cancer and supportive reimbursement policies in countries, such as; the US and Canada are expected to play a substantial role in driving the market in the assessment period.

Europe is anticipated to acquire the second largest market share owing to the rising government support for research & development, and the availability of sufficient funds are expected to strengthen the regional market. Also, the expanding geriatric population with the accelerating cases of oral cancer in the region can augment the market in the forecast period.

The APAC market is expected to be the swiftest growing market during the review period owing to the developing healthcare infrastructure. The increasing patient pool is likely to develop the regional market in the coming period. The rise in healthcare expenditure is expected to steer the APAC market in the projection period. The participation of emerging nations like India, China, and Japan can further strengthen the regional market.

The MEA region is anticipated to expand owing to the rising awareness about cancer diagnostics methods with the rising adoption of medical diagnosis modalities.

Key Players

Eminent players of the global oral cancer diagnostics market are Koninklijke Philips NV (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), GE Healthcare (US), Thermo Fisher Scientific Inc. (US), Hitachi Ltd (Japan), Siemens Healthineers (Germany), PeriRx, LLC (US), Vigilant Biosciences, Inc. (US), Canon Medical Systems Corporation (Japan), and QIAGEN (Germany).

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]

Website: https://www.marketresearchfuture.com

#Oral Cancer Diagnostics Market #Oral Cancer Diagnostics Market Size #Oral Cancer Diagnostics Market Share #Oral Cancer Diagnostics Market Growth #Oral Cancer Diagnostics Market Trend #Oral Cancer Diagnostics Market Analysis #Oral Cancer Diagnostics Market Report #Oral Cancer Diagnostics Market Outook

0 notes

pavanpj · 6 months

Text

Radiant Insights: Unraveling the Veterinary Imaging Systems Market Size, Share, and Trends

Global demand for veterinary imaging systems is anticipated to increase at a CAGR of 6.3% from 2023 to 2033. As such, the veterinary imaging systems market is expected to increase from a valuation of US$ 1.9 billion in 2023 to US$ 3.5 billion by 2033-end.

Small companion animals are gaining traction due to increased pet adoption and growing evidence that having a pet has favorable health advantages for people. The adoption of small companion animals is increasing owing to the loneliness due to nuclear families, youngsters moving away from their homes to job locations, many bachelors living alone, and rising pet care spending.

Download a Sample Copy of This Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=177?PJ

Market Growth and Drivers:

The veterinary imaging systems market has been experiencing growth due to the increasing adoption of pets and the rising demand for advanced veterinary care.

Veterinary imaging systems play a crucial role in diagnosing and treating various animal health conditions, including fractures, tumors, cardiovascular issues, and more.

Technological advancements in imaging systems, such as digital radiography, ultrasound, and magnetic resonance imaging (MRI), have enhanced diagnostic accuracy and capabilities.

Types of Veterinary Imaging Systems:

Digital Radiography: Digital X-ray systems provide high-quality images with reduced radiation exposure. They are commonly used for bone and chest imaging.

Ultrasound: Veterinary ultrasound systems are used for imaging soft tissues, abdominal organs, and reproductive organs in animals. They are non-invasive and can provide real-time imaging.

Computed Tomography (CT): CT scanners offer detailed cross-sectional images of the body and are particularly useful for diagnosing complex conditions.

Magnetic Resonance Imaging (MRI): Veterinary MRI systems use magnetic fields and radio waves to create detailed images of tissues, joints, and the central nervous system.

Nuclear Imaging: This includes techniques like scintigraphy and positron emission tomography (PET) used for specific diagnostic purposes.

Market Trends and Developments:

Portable and Point-of-Care Imaging: Portable and point-of-care imaging systems are gaining popularity as they allow veterinarians to conduct imaging studies directly at the patient’s location.

Advanced Imaging Modalities: Advancements in technology are leading to more advanced imaging modalities with higher resolution and faster scanning times, enabling quicker and more accurate diagnoses.

Integration of AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning technologies is enhancing image analysis and aiding in the diagnosis of various conditions.

Telemedicine and Remote Consultations: Telemedicine and remote consultations are becoming more common, allowing veterinarians to collaborate and seek expert opinions remotely using imaging data.

Challenges:

Cost of Equipment: High costs associated with purchasing and maintaining advanced veterinary imaging equipment can be a barrier for smaller veterinary practices.

Technical Expertise: Operating and interpreting imaging systems require specialized training and expertise, which may be a challenge for some veterinary professionals.

Animal Restraint: Keeping animals still during imaging procedures can be challenging, particularly for certain species and conditions.

Global Market Players:

The veterinary imaging systems market is competitive and includes both established medical imaging companies and specialized veterinary equipment manufacturers.

Key players include companies like IDEXX Laboratories, Inc., Esaote SpA, Heska Corporation, Fujifilm Holdings Corporation, and Carestream Health, among others.

0 notes

insightslicelive · 2 years

Text

Positron Emission Tomography (PET) Systems Market Growth Outlook, Regional Insights, Size Estimation to 2032 | Zecotek Photonics, Brain Biosciences, GE Healthcare LLC

insightSLICE publishes a Global Positron Emission Tomography (PET) Systems Market from 2023 to 2032 research report that assesses the industry and significant market trends, as well as historical and forecasted market data. The study also includes market overview, as well as definitions and applications. Get a FREE Sample Copy @ https://www.insightslice.com/request-sample/1162 The exhaustive…

View On WordPress

#Future Trends of Positron Emission Tomography (PET) Systems industry #Positron Emission Tomography (PET) Systems #Positron Emission Tomography (PET) Systems manufacturing Vendors #Positron Emission Tomography (PET) Systems market #Positron Emission Tomography (PET) Systems market share #Positron Emission Tomography (PET) Systems market size #Positron Emission Tomography (PET) Systems market SWOT analysis #Scope of Positron Emission Tomography (PET) Systems industry

0 notes

researchinsighthub · 8 months

Text

Nuclear Imaging Equipment Market Size, Share, CAGR, Worth, Key Players, Analysis & Forecast 2032

Emergen Research's latest market research report, titled Global Nuclear Imaging Equipment Market, provides estimated market size and shares, latest industry trends, global market growth rates, key drivers and opportunities, constraints, product segmentation, and major market players. Cost structure, market size, competitive landscape, product portfolio and specifications, and company profiles.

This report is a fair prototype of the Nuclear Imaging Equipment-industry containing an in-depth study of the global Nuclear Imaging Equipment market. This report serves as a valuable source of data and information related to this industry. It covers various industry aspects with a particular focus on market scope and application areas. The report identifies the fundamental business strategies adopted by industry experts and offers an insightful study on the value chains and distribution channels of the global market. The report authors have also analyzed current industry trends, growth potential, current overview, and market limitations.

The global nuclear imaging equipment market size was USD 2.97 Billion in 2022 and is expected to register a steady revenue CAGR of 4.9% during the forecast period, according to latest analysis by Emergen Research. The Nuclear Imaging Equipment market has experienced substantial growth in recent years, driven by advancements in technology, increasing prevalence of chronic diseases, and the growing demand for accurate diagnostic imaging. Nuclear imaging involves the use of radioactive substances to create images of the body's organs and tissues, allowing healthcare professionals to diagnose and monitor various medical conditions. It is widely used in cardiology, oncology, neurology, and other medical specialties.

A report by the International Atomic Energy Agency (IAEA) stated that the number of PET-CT and SPECT-CT units worldwide has been steadily increasing over the years, indicating the growing adoption of nuclear imaging technologies. Furthermore, the Centers for Medicare and Medicaid Services (CMS) reported that the reimbursement rates for nuclear imaging procedures have remained stable, demonstrating the importance of these imaging modalities in clinical practice.

One of the key drivers of the Nuclear Imaging Equipment market is the continuous technological advancements in imaging systems. Manufacturers are constantly developing innovative technologies that enhance image quality, reduce radiation exposure, and improve the overall efficiency of nuclear imaging procedures. For example, the introduction of hybrid imaging systems such as positron emission tomography-computed tomography (PET-CT) and single-photon emission computed tomography-computed tomography (SPECT-CT) has revolutionized diagnostic imaging by combining anatomical and functional information in a single scan. These advancements have led to more accurate diagnoses, improved patient outcomes, and increased adoption of nuclear imaging equipment.

The increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, is another major driver of the Nuclear Imaging Equipment market. Nuclear imaging techniques play a crucial role in the early detection, staging, and monitoring of these diseases. For instance, PET-CT scans are widely used in oncology to identify tumor location, assess treatment response, and monitor disease progression. As the global burden of chronic diseases continues to rise, there is a growing demand for advanced diagnostic tools like nuclear imaging equipment to aid in disease management and improve patient care.

However, there are also certain restraints and challenges that the Nuclear Imaging Equipment market faces. One of the primary restraints is the high cost associated with these imaging systems. Nuclear imaging equipment is complex and requires specialized infrastructure, radioactive materials, and trained personnel, making it expensive to procure and operate. The cost factor can limit the adoption of nuclear imaging equipment, particularly in resource-constrained healthcare settings. Additionally, the strict regulatory requirements and safety considerations associated with the use of radioactive materials pose challenges for market growth.

Additionally, researchers have closely examined the significant changes in the market following the coronavirus outbreak. This is the latest report examining the economic situation of the Nuclear Imaging Equipment industry after the current pandemic. The COVID-19 pandemic has significantly changed various aspects of the global Nuclear Imaging Equipment market scenario. The latest report provides a comprehensive COVID-19 impact analysis of the market, helping readers to know about the significant impact of the outbreak on the current and future scenarios of this business.

Get Free Sample Report, visit @https://www.emergenresearch.com/request-sample/1939

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Nuclear Imaging Equipment market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Nuclear Imaging Equipment market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Nuclear Imaging Equipment market.

To seek a discount on this report, click on the link: @https://www.emergenresearch.com/request-discount/1939

Competitive Terrain:

The global Nuclear Imaging Equipment industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

Leading Market Players Profiled in the Report:

Siemens Healthcare GmbH, Koninklijke Philips N.V., DIGIRAD HEALTH, INC., GE HealthCare., SurgicEye GmbH, Rigaku Corporation, Neusoft Corporation., Segami, FUJIFILM Holdings Corporation, and Mirion Technologies, Inc

Regional Outlook:

North America (the U.S., Canada, Mexico)

Europe (the U.K., Germany, France, Italy)

Asia Pacific (India, China, Japan, Korea)

Latin America (Brazil, Argentina, Ecuador, Chile)

Middle East & Africa (Egypt, Turkey, Saudi Arabia, Iran)

Key reasons to buy the Global Nuclear Imaging Equipment Market report:

The latest report comprehensively studies the global Nuclear Imaging Equipment market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.

The report offers an insightful analysis of the regional outlook of the market.

It offers a detailed account of the end-use applications of the products & services offered by this industry.

The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request customization of the report @https://www.emergenresearch.com/request-for-customization/1939

Related Reports:

water treatment biocides market https://www.emergenresearch.com/industry-report/water-treatment-biocides-market

ai in banking market https://www.emergenresearch.com/industry-report/ai-in-banking-market

computer aided diagnostics market https://www.emergenresearch.com/industry-report/computer-aided-diagnostics-market

robotics surgical simulation systems market https://www.emergenresearch.com/industry-report/robotics-surgical-simulation-systems-market

powered agriculture equipment market https://www.emergenresearch.com/industry-report/powered-agriculture-equipment-market

Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.

About Emergen Research Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy

Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: https://www.emergenresearch.com/ Direct Line: +1 (604) 757-9756 E-mail: [email protected] Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

0 notes

vanshika393 · 9 months

Text

Medical Imaging Equipment Market Size Expected To Acquire USD 48,786.03 million By 2030 At CAGR of 5.60%

The latest market report published by Credence Research, Inc. “Global Medical Imaging Equipment Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2030. The market for medical imaging equipment has been expanding steadily in recent years, and between 2023 and 2030, it is anticipated to rise at a CAGR of 5.60%. The market was estimated to be worth USD 31,548.9 million in 2022, and it is anticipated to be worth USD 48,786.03 million in 2030.

Medical Imaging Equipment Market Overview:

The Medical Imaging Equipment Market refers to the global industry that produces and sells various devices used to create visual representations of the interior of a body for clinical analysis and medical intervention. These devices play a crucial role in diagnosing, monitoring, and treating various medical conditions by providing valuable insights into the structure and functioning of internal organs and tissues. The market includes a wide range of imaging modalities, each with its own technology and applications.

Types of Medical Imaging Equipment:

Computed Tomography (CT) Scanners: CT scanners use a series of X-ray images taken from different angles to create detailed cross-sectional images of the body. They are especially useful for visualizing internal structures in 3D.

Magnetic Resonance Imaging (MRI) Systems: MRI uses strong magnetic fields and radio waves to generate detailed images of soft tissues, organs, and the nervous system. It's particularly valuable for diagnosing neurological and musculoskeletal conditions.

Ultrasound Machines: Ultrasound imaging uses high-frequency sound waves to create images of internal structures. It's commonly used for monitoring pregnancies, examining organs, and guiding procedures.

Nuclear Medicine Equipment: This category includes equipment like Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) scanners. These technologies use radioactive tracers to visualize organ function and metabolism.

Partnerships and Collaborations:

Siemens Healthineers and Novartis: Siemens Healthineers entered into a partnership with Novartis to develop and commercialize assays measuring blood levels of certain therapeutic drugs using Siemens' Atellica Solution immunoassay analyzer. This collaboration aimed to enhance personalized treatment and monitoring of patients.

Philips and B. Braun Melsungen: Philips and B. Braun Melsungen collaborated in 2020 to provide an integrated regional solution for continuous ultrasound-guided regional anesthesia. The collaboration aimed to improve patient care during surgery by combining B. Braun's regional anesthesia expertise with Philips' ultrasound technology.

GE Healthcare and Roche: GE Healthcare and Roche collaborated in 2020 to develop and market digital diagnostics solutions, combining Roche's expertise in in-vitro diagnostics with GE Healthcare's expertise in medical imaging and monitoring.

Acquisitions:

Philips Acquires BioTelemetry: Philips acquired BioTelemetry, a company specializing in remote cardiac diagnostics and monitoring. This acquisition aimed to expand Philips' remote patient monitoring offerings and enhance its digital healthcare solutions.

Siemens Healthineers Acquires Varian Medical Systems: Siemens Healthineers completed the acquisition of Varian Medical Systems, a company known for its advanced radiation therapy solutions for cancer treatment. This acquisition aimed to strengthen Siemens Healthineers' oncology portfolio.

Canon Medical Systems Acquires Delft Imaging Systems: Canon Medical Systems acquired Delft Imaging Systems, a company focused on providing medical imaging solutions for low-resource settings. This acquisition aimed to enhance Canon's efforts to provide healthcare solutions to underserved regions.

Browse 240 pages report By End-User (Hospitals, Diagnostic Imaging Centers, Specialty Clinics, Ambulatory Care Centers) By Technology (Digital Imaging, Analog Imaging, 3D and 4D Imaging, Portable and Point-of-Care Imaging) By Specialty and Advanced Features Contrast-Enhanced Imaging, Functional Imaging, Interventional Imaging, Molecular Imaging) Growth, Future Prospects & Competitive Analysis, 2016 – 2030 - https://www.credenceresearch.com/report/medical-imaging-equipment-market

Here are some of the significant growth factors:

Technological Advancements: Continuous advancements in medical imaging technology, such as MRI, CT scans, ultrasound, and X-ray systems, have played a pivotal role in market growth. Improved imaging quality, faster scans, and reduced radiation exposure have expanded the applications and adoption of these technologies.

Aging Population: The global population is aging, leading to an increased demand for medical imaging services. As people age, they are more likely to require medical imaging for diagnostic purposes and disease management.

Rising Chronic Diseases: The prevalence of chronic diseases such as cancer, cardiovascular diseases, and orthopedic conditions is on the rise. These conditions often require diagnostic imaging for accurate diagnosis and treatment planning.

Emerging Markets: Developing countries are expanding their healthcare infrastructure, increasing access to medical imaging services. This has led to a significant market growth in regions like Asia-Pacific, Latin America, and the Middle East.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Medical Imaging Equipment Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Medical Imaging Equipment Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/medical-imaging-equipment-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/ambulatory-surgery-centers-market

https://www.credenceresearch.com/report/veterinary-surgical-sutures-market

Browse Our Blog: https://www.linkedin.com/pulse/medical-imaging-equipment-market-grow-steadily-over-cagr-shukla

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

#helathcare

0 notes

poojascmi · 10 months

Text

Global Neuroscience Market Is Estimated To Witness High Growth Owing To Increasing Technological Advancements And Rising Prevalence of Neurological Disorders

The global Neuroscience Market is estimated to be valued at US$ 32.75 billion in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

The field of neuroscience focuses on the study of the nervous system and how it impacts behavior and cognitive functions. The market for neuroscience products encompasses various technologies and devices used for diagnostics, therapeutic interventions, and research purposes. These products include neuroimaging systems, electrophysiology devices, neurostimulation devices, and others. The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy has driven the demand for neuroscience products.

B) Market Dynamics:

The market dynamics of the global Neuroscience Market are influenced by two key drivers:

1. Increasing technological advancements: The advancements in neuroscience technology have led to the development of sophisticated tools and techniques for studying the brain and nervous system. For example, neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) have enabled researchers to visualize brain structures and functions, aiding in the diagnosis and treatment of neurological disorders.

2. Rising prevalence of neurological disorders: The increasing prevalence of neurological disorders worldwide has created a significant demand for neuroscience products. According to the World Health Organization (WHO), approximately 1 billion people worldwide suffer from neurological disorders. This has prompted healthcare providers to adopt advanced neuroscience technologies for accurate diagnosis and effective treatment.

C) Market Key Trends:

One key trend in the Neuroscience Market is the growing adoption of neurostimulation devices for therapeutic interventions. Neurostimulation devices such as deep brain stimulation (DBS) devices and transcranial magnetic stimulation (TMS) devices have shown promising results in the management of neurological conditions. For instance, DBS devices have been proven effective in treating Parkinson's disease and essential tremors by delivering electrical impulses to specific brain areas, thus reducing symptoms.

D) SWOT Analysis:

- Strengths: Increasing technological advancements and widespread availability of neuroscience products.

- Weaknesses: High costs associated with neuroscience products and limited awareness about the benefits of these technologies.

- Opportunities: Growing demand for personalized medicine and increasing research funding in neuroscience.

- Threats: Stringent regulatory requirements and ethical concerns associated with brain research.

E) Key Takeaways:

In terms of market size, the global Neuroscience Market is expected to witness high growth, exhibiting a CAGR of 4.1% over the forecast period. This growth can be attributed to increasing technological advancements and the rising prevalence of neurological disorders.

From a regional perspective, North America is expected to dominate the market due to the presence of well-established healthcare infrastructure and a large patient population. However, the Asia-Pacific region is expected to witness the fastest growth, driven by a growing awareness about neurological disorders and increasing healthcare expenditure.

Key players operating in the global Neuroscience Market include Alpha Omega, Inc., GE Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Scientifica Ltd., and others. These companies focus on collaborations, product launches, and mergers and acquisitions to strengthen their market position and expand their product portfolios.

#Neuroscience Market #Neuroscience Market Demand #Neuroscience Market Forecast #Neuroscience Market Insights #Neuroscience Market Analysis #Neuroscience Market Trends #brain imaging #neurostimulation #neuroinformatics #Coherent Market Insights

1 note · View note

priyanshisingh · 10 months

Text

Radiopharmaceutical Theranostics Market Size, Industry Share, Growth Demand, Supply Chain, Trends Future Outlook, Forecast 2030

The latest market report published by Credence Research, Inc. “Global Radiopharmaceutical Theranostics Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. Steady growth in recent years is expected to grow at a CAGR of 11.90% between 2022 and 2030. The market was valued at USD 1.6 billion in 2022 and is expected to reach USD 3.52 billion in 2030.

Radiopharmaceutical theranostics market dynamics play a crucial role in the advancement of personalized medicine and targeted therapy. The term "theranostics" combines diagnostics and therapy, highlighting the dual functionality of radiopharmaceuticals in both identifying disease biomarkers and delivering therapeutic interventions. This rapidly evolving field is driven by several key factors that shape its dynamic landscape. Technological advancements in imaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), have significantly improved diagnostic accuracy and aided treatment decision-making processes. Additionally, the increasing prevalence of chronic diseases, including cancer and cardiovascular disorders, has surged the demand for precise molecular imaging tools capable of guiding effective treatment strategies.

Global Disease Burden Amplifying Market Growth

The mounting global burden of chronic diseases, particularly cancer and neurodegenerative disorders, plays a pivotal role in propelling the radiopharmaceutical theranostics market. Advances in theranostics have shown significant promise in addressing these health challenges, making them a focal point in the healthcare sector's battle against chronic diseases.

Technological Innovations as Market Catalysts

Innovation is at the heart of the radiopharmaceutical theranostics market's surge. Groundbreaking developments in medical imaging technologies, such as PET and SPECT, and novel radioisotope therapies are stimulating market growth. The fusion of these technologies has birthed an era of targeted, efficient, and minimally invasive treatment options.

Market Segmentation:

By Application: Cancer Remains the Leading Segment

Cancer theranostics remains the predominant market segment, driven by the ever-increasing global cancer incidence. The advent of radiopharmaceuticals like Lutathera and Azedra has transformed the oncology landscape, offering groundbreaking solutions for neuroendocrine tumors and pheochromocytoma.

By End-user: Hospitals and Diagnostic Centers Lead the Way

Hospitals and diagnostic centers represent the leading end-user segment. These institutions are at the forefront of adopting radiopharmaceutical theranostics due to their comprehensive treatment capabilities and access to advanced medical imaging modalities.

Browse 210 pages report Radiopharmaceutical Theranostics Market By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Radium-223, Fluorine-18) By Application (Oncology, Cardiology, Others) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/radiopharmaceutical-theranostics-market

Regional Market Dynamics:

North America: The Dominant Player

North America retains its stronghold on the radiopharmaceutical theranostics market. This is attributable to the region's robust healthcare infrastructure, advanced research facilities, and high adoption rate of innovative medical technologies.

Europe and Asia-Pacific: Regions on the Rise

Europe and Asia-Pacific regions are also notable market players. Europe's progress is driven by its sophisticated healthcare systems and a strong focus on research and development. Asia-Pacific, meanwhile, benefits from a booming healthcare sector and an increasing prevalence of chronic diseases.

Key Market Players:

Dominant players in the global radiopharmaceutical theranostics market include Novartis AG, Advanced Accelerator Applications, and Progenics Pharmaceuticals. Their innovative strides in radioisotope production, medical imaging, and theranostic applications shape the industry's landscape and future trajectory.

The Road Ahead: Future Perspectives in Radiopharmaceutical Theranostics

As we look to the future, the radiopharmaceutical theranostics market is set to witness continued growth. Aided by technological advancements, increased healthcare spending, and an unyielding commitment to improving patient outcomes, the theranostic revolution will continue to flourish, transforming the way we diagnose and treat diseases.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Radiopharmaceutical Theranostics Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Radiopharmaceutical Theranostics Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/radiopharmaceutical-theranostics-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/big-data-spending-in-healthcare-market

Related Report: https://www.credenceresearch.com/report/microbiological-safety-cabinets-market

Browse Our Blog: https://www.linkedin.com/pulse/radiopharmaceutical-theranostics-market-grow-steadily-priyanshi-singh

Browse Our Blog: https://tealfeed.com/radiopharmaceutical-theranostics-market-size-worth-usd-lk484

About Us -

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

0 notes

market-insider · 2 years

Text

Preclinical Imaging Market Report | Multimodal Imaging Segment Expected To Witness Significant Growth

The global preclinical imaging market size is expected to reach USD 5.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.8% from 2022 to 2030. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create additional demand for this market.

Gain deeper insights on the market and receive your free copy with TOC now @: Preclinical Imaging Market Report

Nuclear medicine techniques (primarily, positron emission tomography [PET] and single-photon emission computed tomography [SPECT]), optical imaging, micro computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT) and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality.

The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the market growth.

The market's prominent competitors are taking different initiatives such as funding’s and acquisitions of medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, In November 2021, Bruker Corporation acquired MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging systems. This acquisition is expected to strengthen Bruker's position as a leading supplier in preclinical and translational imaging research.

#Preclinical Imaging Market Size & Share #Preclinical Imaging Market Latest Trends #Preclinical Imaging Market Growth Forecast #COVID-19 Impacts On Preclinical Imaging Market #Preclinical Imaging Market Revenue Value #Global Preclinical Imaging Market

0 notes

petnews2day · 2 years

Text

PET-CT Scanner Device Market Improvement in Technology is Expected to Drive the Growth of the Market

New Post has been published on https://petnews2day.com/pet-industry-news/pet-travel-news/pet-ct-scanner-device-market-improvement-in-technology-is-expected-to-drive-the-growth-of-the-market/

PET-CT Scanner Device Market Improvement in Technology is Expected to Drive the Growth of the Market

PET-CT Scanner Device Market

Positron Emission Tomography (PET) and Computer Tomography (CT) scanners are combined to provide utmost diagnostic capabilities to patients

SEATTLE, WASHINGTON, UNITED STATES, November 10, 2022 /EINPresswire.com/ — Coherent Market Insights have added a new research study on Title PET-CT Scanner Device Market, Global Outlook and Forecast 2022-2028 with detailed information & Key Players Such as General Electric Co., Hitachi, Ltd., Mediso Ltd., Koninklijke Philips N.V., PerkinElmer, Inc., Positron Corporation, Siemens AG, Shimadzu Corporation, Toshiba Corporation, and Yangzhou Kindsway Biotech Co. Ltd. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans. The facts and data are well presented in the PET-CT Scanner Device report using diagrams, graphs, pie charts, and other pictorial representations with respect to its current trends, dynamics, and business scope & key statistics.

Click To get SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.coherentmarketinsights.com/insight/request-sample/2169

Positron Emission Tomography (PET) and Computer Tomography (CT) scanners are combined to provide utmost diagnostic capabilities to patients. This combination produces a highly sensitive imaging and detects diseases at an early stage that are often undetected by CT alone or by other imaging procedures such as magnetic resonance imaging (MRI). The CT component of the system adds anatomical information to the PET scan and provides accurate information on the location of disease in the body. These equipment are used for diagnosis of different types of cancers, such as colorectal cancers and lymphomas, as well as some neurological and cardiac conditions.

Impact Analysis – PET-CT Scanner Device Market Research

Analysts at Coherent Market Insights constantly monitor the PET-CT Scanner Device industry factors with impacts of current events; with this study an update of how industry players have tackled latest scenario and what key strategies have made significant difference is showcased.

Key Highlights from PET-CT Scanner Device Market Study

𝐑𝐞𝐯𝐞𝐧𝐮𝐞 𝐚𝐧𝐝 𝐒𝐚𝐥𝐞𝐬 𝐄𝐬𝐭𝐢𝐦𝐚𝐭𝐢𝐨𝐧 – Historical Revenue and sales volume is presented and further data is triangulated with top-down and bottom-up approaches to forecast complete market size and to estimate forecast numbers for key regions covered in the report along with classified and well recognized Types and end-use industry. Additionally, macroeconomic factor and regulatory policies are ascertained in PET-CT Scanner Device industry evolution and predictive analysis.

𝐅𝐈𝐕𝐄 𝐅𝐎𝐑𝐂𝐄𝐒 𝐀𝐍𝐀𝐋𝐘𝐒𝐈𝐒 – In order to better understand PET-CT Scanner Device market condition five forces analysis is conducted that includes Bargaining power of buyers, Bargaining power of suppliers, Threat of new entrants, Threat of substitutes, and Threat of rivalry.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧 – Leading players have been studied from PET-CT Scanner Device Industry depending on their company profile, product portfolio, capacity, product/service price, sales, and cost/profit.

𝐃𝐞𝐦𝐚𝐧𝐝 & 𝐒𝐮𝐩𝐩𝐥𝐲 𝐚𝐧𝐝 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬 – PET-CT Scanner Device report additionally provides distribution, Production, Consumption & EXIM** (Export & Import). ** If applicable

Have Any Query? Ask Our Expert: https://www.coherentmarketinsights.com/insight/talk-to-analyst/2169

𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥𝐥𝐲, 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐫𝐞𝐠𝐢𝐨𝐧𝐬 𝐭𝐨𝐠𝐞𝐭𝐡𝐞𝐫 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 𝐥𝐢𝐬𝐭𝐞𝐝 𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥/𝐥𝐨𝐜𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭𝐬 𝐚𝐫𝐞 𝐟𝐮𝐥𝐥𝐲 𝐢𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐞𝐝:–

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) – Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) – North America (U.S., Canada, and Mexico) – South America (Brazil, Chile, Argentina, Rest of South America) – MEA (Saudi Arabia, UAE, South Africa)

The Latest Trends, Product Portfolio, Demographics, Geographical segmentation, and Regulatory Framework of the PET-CT Scanner Device Market have also been included in the study.

PET-CT Scanner Device Market Key Players: General Electric Co., Hitachi, Ltd., Mediso Ltd., Koninklijke Philips N.V., PerkinElmer, Inc., Positron Corporation, Siemens AG, Shimadzu Corporation, Toshiba Corporation, and Yangzhou Kindsway Biotech Co. Ltd.

𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

Global PET-CT Scanner Device Market, By Detector Type:

FluroDeoxyGlucose (FDG) 62CU ATSM FMISO Gallium Thallium Others

Global PET-CT Scanner Device Market, By Setting:

Fixed Mobile

Global PET-CT Scanner Device Market, By Application:

Cardiology Oncology Neurology Others

Global PET-CT Scanner Device Market, By End User:

Hospitals Diagnostic Centers Research Institutes

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2169

Introduction About PET-CT Scanner Device Market

PET-CT Scanner Device Market Size (Sales) Market Share by Type (Product Category) PET-CT Scanner Device Market by Application/End Users PET-CT Scanner Device Sales (Volume) and Market Share Comparison by Applications Global PET-CT Scanner Device Sales and Growth Rate (2022-2028) PET-CT Scanner Device Competition by Players/Suppliers, Region, Type, and Application PET-CT Scanner Device (Volume, Value, and Sales Price) table defined for each geographic region defined. PET-CT Scanner Device Players/Suppliers Profiles and Sales Data Key Raw Materials Analysis & Price Trends Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis ……..and view more in complete table of Contents

𝐊𝐞𝐲 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐀𝐧𝐬𝐰𝐞𝐫𝐞𝐝:

1. What is the market size and CAGR of the PET-CT Scanner Device Market during the forecast period? 2. How is the growing demand impacting the growth of PET-CT Scanner Device Market shares? 3. What is the growing demand of the PET-CT Scanner Device Market during the forecast period? 4. Who are the leading vendors in the market and what are their market shares? 5. What is the impact of the COVID-19 pandemic on the APAC PET-CT Scanner Device Market?

Thanks for reading this article; Coherent Market Insights also offers Custom Research services providing focused, comprehensive and tailored research according to clientele objectives. Thanks for reading this article; you can also get individual chapter wise sections or region wise reports like North America, Europe, or Asia

To Purchase Report, Click Here – https://www.coherentmarketinsights.com/insight/buy-now/2169

𝐀𝐛𝐨𝐮𝐭 𝐮𝐬:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah Coherent Market Insights Pvt. Ltd. +1 206-701-6702 email us here Visit us on social media: Facebook Twitter LinkedIn Other

You just read:

News Provided By

November 10, 2022, 10:50 GMT

EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™, tries to define some of the boundaries that are reasonable in today’s world. Please see our Editorial Guidelines for more information.

Submit your press release

!function(f,b,e,v,n,t,s) if(f.fbq)return;n=f.fbq=function()n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments); if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)(window, document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '251889322717210'); fbq('track', 'PageView');

#Pet Travel News

0 notes

researchvishal · 2 years

Text

Positron Emission Tomography (PET) Scanners Market Study: An Emerging Hint of Opportunity by 2031

The global positron emission tomography (PET) scanners market size was valued at over US$ 1.2 Bn in 2021 and is expected to exhibit a CAGR of close to 5.1% over the forecast period.

Key Takeaways:

By product, full-ring PET scanner is expected to hold over 86.2% of the total market share by 2031.

Sales in the oncology segment accounted for over 85.2% of market share in 2020, owing to the increasing incidence of chronic diseases and cancer.

Based on detector type, demand in the lutetium oxyorthosilicate (LSO) segment to held over 37.3% of market share in 2020.

Hospitals dominate end user segment with a share of around 34.9% in 2020 due to increasing patient inflow after COVID-19 outbreak.

The concept of Positron Emission Tomography (PET) Scan is a nuclear medicine imaging technology was established in early 1970s. Ever since the technology has evolved into routine clinical imaging modality, revolutionizing the process of diseases diagnosis and management into more effective fashion.

PET is a molecular imaging technology that detects the concentration and pharmacokinetics of radiotracer molecules that are labelled with radioisotopes. This helps to diagnose and determine the severity of a various diseases such as neurological disorders, cardiovascular disorders, cancer, gastrointestinal and various others.

Based on the operational and geometrical capabilities of PET scanners, the systems are classified as full ring PET systems and partial ring PET systems. Advancements in technological performance of these systems are always associated with higher cost, limiting its widespread utilization in clinical PET imaging.

Rising prevalence of chronic disorders such as cancer and cardiovascular disorders, coupled with greater awareness towards physical wellbeing and limitations of conventional PET scanner is spurring demand for effective diagnostic techniques, thereby augmenting growth of the market.

Positron Emission Tomography (PET) Scanners have continued to improve image quality and performance over the last few years. Technological improvements such as managing dose, reduced imaging time and enhanced lesion detectability have increased PET’s functionality, thus making it easier to interpret and diagnose various life-threatening disorders.

Key Market Segments Covered

By Product:

Full-ring PET scanner

Partial-ring PET scanner

By Application:

Oncology

Cardiology

Neurology

Others

By Detector Type:

Bismuth Germanium Oxide (BGO)

Lutetium Oxyorthosilicate (LSO)

Gadolinium Oxyorthosilicate (GSO)

Lutetium Fine Silicate (LFS)

Lutetium Yttrium Orthosilicate

By End User:

Hospitals

Diagnostic Centers

PET Centers

Research Institute

“Ongoing technological advancements in PET scanners, copled with increasing applications in diagnostic centers and research institutes will propel the growth of the market in the forthcoming years” says a FMI analyst.

For more Information @ https://www.futuremarketinsights.com/reports/positron-emission-tomography-scanners-market

Who is winning?

Acquisitions, mergers, expansion, and product launches are the key strategies adopted by manufacturers to increase consumer base in different geographies. For instance:

In January 2020, Koninklijke Philips N.V. introduced its advanced solutions called Vereos Digital PET/CT (world’s first and only fully digital, clinically proven, PET/CT solution), an AI-powered solution for precision diagnosis at IRIA 2020.

0 notes